BRISTOL-MYERS SQUIBB COMPANY |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.92 USD | -0.64% |
|
-1.57% | -14.25% |
| May. 01 | HSBC Adjusts Price Target on Bristol-Myers Squibb to $45 From $50 | MT |
| May. 01 | Editas Medicine, Bristol-Myers Squibb Extend Alpha-Beta T Cell Collaboration | MT |
ETFs positioned on Bristol-Myers Squibb Company
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 12.97% | 215 M€ | +11.97% | - | |
| 4.99% | 2 M€ | -.--% | ||
| 4.01% | 18 M€ | +3.01% | - | |
| 2.63% | 23 M€ | +8.02% | - | |
| 2.37% | 2 M€ | -25.75% | ||
| 2.29% | 32 M€ | -0.39% | - | |
| 2.08% | 9 M€ | -.--% | - | |
| 1.90% | 16 M€ | -3.37% | ||
| 1.85% | 2 M€ | +6.77% | ||
| 1.43% | 5 M€ | -72.95% | - | |
| 1.42% | 9 M€ | -4.31% | - | |
| 1.37% | 26 M€ | +16.85% | - | |
| 1.26% | 846 M€ | +2.33% | ||
| 1.00% | 96 M€ | -1.46% | ||
| 0.99% | 10 M€ | +4.60% | ||
| 0.83% | 105 M€ | +5.14% | ||
| 0.82% | 8 M€ | -.--% | ||
| 0.80% | 2,510 M€ | +10.02% | ||
| 0.78% | 3 M€ | +15.16% | - | |
| 0.78% | 13 M€ | -.--% | - |
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
Pharmaceuticals
Calendar
2024-05-07
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
HOLD
Number of Analysts
27
Last Close Price
44.21
USD
Average target price
53.37
USD
Spread / Average Target
+20.72%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -14.25% | 89.62B | |
| +30.12% | 699B | |
| +25.07% | 571B | |
| -4.62% | 364B | |
| +18.30% | 326B | |
| +2.89% | 286B | |
| +14.68% | 236B | |
| +4.71% | 198B | |
| -12.43% | 194B | |
| -3.21% | 154B |
- Stock Market
- Equities
- BMY Stock
- Funds and ETFs Bristol-Myers Squibb Company
